This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.
These are among Deloitte’s predictions for life sciences and the future for drugs companies and their operations, from The Future Awakens: Life Sciences and Health Care Predictions 2022 (Deloitte, November
A study published in December by Deloitte showed that R&D costs have doubled in eight years, while peak sales forecasts have halved.
The research by Deloitte’s Centre for Health Solutions found returns had declined 1.8 percentage points from 3.7% in 2017. ... Deloitte says the industry needs to tackle the problem with new ways of working and emphasis on finding the right talent.
According to a Deloitte report, AI ‘can help analyse large data sets from sources such as clinical trials, health records, genetic profiles and preclinical studies; within this data, it can recognise ... Deloitte also suggests AI can help improve study
According to a Deloitte survey, 75% of British companies are now pessimistic about Brexit after weak investment and waning revenues in the most recent financial quarter.
A Deloitte report on the application of blockchain to healthcare published in 2016 predicted that the technology could “provide a new model for health information exchanges (HIE) by making electronic medical
More from news
Approximately 2 fully matching, plus 17 partially matching documents found.
The Prescrypt project, spearheaded by Deloitte in the Netherlands, is pursuing a completely different focus by working to put patients’ drug prescriptions on the blockchain for secure communication, usage tracking and
Deloitte’s Future of Work initiative highlights the increasingly important role that contractors, freelancers and external experts play in building the flexible and agile teams that companies need.
at Deloitte Strategy Consulting, who specialises in the biotech sector. ... Deloitte’s Xiaofeng believes that China’s growth will benefit Europe and the rest of the world.
Steve Wexler has worked with ADP, Gallup, Deloitte, Convergys, Consumer Reports, The Economist, ConEd, D&B, Marist, Tradeweb, Tiffany, McKinsey &Company, and many other organisations to help them understand and visualise
More than half the leading life science companies polled by Deloitte in 2017 were developing or significantly improving their real-world data (RWD) capabilities.
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
Prior to that, she held several senior communications roles, including chief communications officer at Deloitte, as well as senior roles at Novartis, Pfizer and leadership roles at biotech and healthcare communications
Stockdale arrives at the company from e-Therapeutics, where he had been financial controller since 2012, and has also previously served at Deloitte as a senior manager.
Previously healthcare and life sciences partner at Deloitte Consulting, Vogt has experience advising companies in the medtech, healthcare and pharmaceutical industries in implementing and improving strategies. ... Prior to his experience at Deloitte
Prior to this, Souza held the role of chief financial officer at Aetna, overseeing its guaranteed products business, and has also held senior leadership positions at Deloitte and PriceWaterhouseCooper.
He brings 20 years of financial and managerial experience to the role, having worked at Deloitte, Eaga, PriceWaterhouseCoopers and Barclays, where he headed up its North East corporate banking division.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Natalie Yeadon, Co-owner/Managing Director at Impetus Digital, talks to Ladana Edwards and Thomas De Bruyne from Deloitte Europe about the future of education and learning.
Deloitte, 2019.Last accessed February 2020, available at: ). Accenture, 2019. Last accessed February 2020, available at: . Public Health England. Last accessed February 2020, available at: . 44 (0) 20 7009 3100. Address:.
RWD and RWE are high on the list of priorities for the top 20 pharmaceutical companies. According to Deloitte, 90% of them are investing in RWE capabilities across the entire product
New York, NY: 2017. 9. Deloitte. Pharma Adoption of Social Media.
Deloitte Digital.
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...